Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07526402

Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation in Healthy Individuals

Investigation of the Acute Effects of Different Frequency Applications of Transcutaneous Auricular Vagus Nerve Stimulation on Autonomic Physiological Responses in Healthy Individuals

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Sinop University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This randomized, participant-blinded, sham-controlled crossover study aims to investigate the acute effects of different frequency applications of transcutaneous auricular vagus nerve stimulation (taVNS) on autonomic physiological responses in healthy adults. Participants will receive sham (0 Hz), 10 Hz, 25 Hz, 50 Hz, and 100 Hz taVNS in separate sessions with washout periods between visits. Heart rate variability, blood pressure, pulse rate, respiratory rate, and subjective discomfort will be assessed before and after each intervention session.

Detailed description

The vagus nerve is a major regulator of the parasympathetic branch of the autonomic nervous system. Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique applied to auricular regions innervated by the auricular branch of the vagus nerve. Although taVNS has been reported to modulate autonomic function, the acute physiological effects of different stimulation frequencies remain insufficiently characterized. This study is designed as a randomized, participant-blinded, sham-controlled crossover trial in healthy adults aged 18 to 40 years. Each participant will undergo five intervention conditions in randomized order: sham (0 Hz), 10 Hz, 25 Hz, 50 Hz, and 100 Hz taVNS. Sessions will be separated by 48 to 72 hours to minimize carryover effects. Each stimulation session will last 10 minutes. Primary autonomic outcomes will be derived from heart rate variability parameters obtained using a Polar H10 chest strap and analyzed with Kubios HRV software. Secondary physiological outcomes will include systolic and diastolic blood pressure, pulse rate, respiratory rate, and subjective discomfort measured using a visual analog scale. The study aims to identify frequency-specific autonomic response profiles and to evaluate whether respiratory rate influences heart rate variability changes associated with taVNS.

Conditions

Interventions

TypeNameDescription
DEVICESham taVNSSham stimulation is delivered under conditions similar to active taVNS without meaningful vagal stimulation.
DEVICEtaVNS 10 HzActive transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 10 Hz.
DEVICEtaVNS 25 HzActive transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 25 Hz.
DEVICEtaVNS 50 HzActive transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 50 Hz.
DEVICEtaVNS 100 HzActive transcutaneous auricular vagus nerve stimulation applied for 10 minutes at 100 Hz.

Timeline

Start date
2026-05-01
Primary completion
2026-05-01
Completion
2026-09-01
First posted
2026-04-13
Last updated
2026-04-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07526402. Inclusion in this directory is not an endorsement.